KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Non-Current Assets (2018 - 2025)

BioNTech SE's Non-Current Assets history spans 8 years, with the latest figure at $6.8 billion for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 70.79% to $6.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.8 billion, a 70.79% increase, with the full-year FY2025 number at $6.6 billion, up 65.76% from a year prior.
  • Non-Current Assets hit $6.8 billion in Q4 2025 for BioNTech SE, up from $6.4 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for BNTX hit a ceiling of $6.8 billion in Q4 2025 and a floor of $803.3 million in Q3 2021.
  • Historically, Non-Current Assets has averaged $3.2 billion across 5 years, with a median of $3.5 billion in 2023.
  • Biggest five-year swings in Non-Current Assets: surged 224.44% in 2023 and later rose 6.37% in 2024.
  • Tracing BNTX's Non-Current Assets over 5 years: stood at $867.7 million in 2021, then skyrocketed by 59.57% to $1.4 billion in 2022, then skyrocketed by 170.35% to $3.7 billion in 2023, then grew by 6.37% to $4.0 billion in 2024, then skyrocketed by 70.79% to $6.8 billion in 2025.
  • Business Quant data shows Non-Current Assets for BNTX at $6.8 billion in Q4 2025, $6.4 billion in Q3 2025, and $6.5 billion in Q2 2025.